BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2021 10:05:39 AM | Browse: 345 | Download: 756
 |
Received |
|
2021-01-24 23:01 |
|
Peer-Review Started |
|
2021-01-24 23:10 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-07 03:53 |
|
Revised |
|
2021-03-19 19:34 |
|
Second Decision |
|
2021-04-25 12:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-25 13:18 |
|
Articles in Press |
|
2021-04-25 13:18 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-11 01:10 |
|
Publish the Manuscript Online |
|
2021-05-13 10:05 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Lukas Hartl, Joshua Elias, Gerhard Prager, Thomas Reiberger and Lukas W Unger |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Austrian Science Fund FWF |
J4396 |
| Wellcome Trust PhD Fellowship for Clinicians |
UNS59491 |
|
| Corresponding Author |
Lukas W Unger, MD, PhD, Doctor, Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, Vienna A-1090, Austria. lukas.unger@meduniwien.ac.at |
| Key Words |
Metabolic dysfunction-associated fatty liver disease; Non-alcoholic fatty liver disease; Portal hypertension; Cirrhosis; Bariatric surgery; Metabolism |
| Core Tip |
No single therapy fits all needs, sometimes resulting in complex clinical decision making. While some etiologies can distinctly be characterized, a multifactorial disease such as metabolic dysfunction-associated fatty liver disease requires thorough assessment of comorbidities and severity of concomitant fibrosis to assess a patient’s overall risk. While (guided) physical exercise is usually safe and well tolerated and strict treatment of diabetes and dyslipidemia is warranted, patients often fail to change their lifestyle, resulting in life-long drug dependency for comorbidities. Bariatric surgery has therefore become a valid option for obese patients and should be offered in eligible patients before liver fibrosis develops. |
| Publish Date |
2021-05-13 10:05 |
| Citation |
Hartl L, Elias J, Prager G, Reiberger T, Unger LW. Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. World J Gastroenterol 2021;27(19): 2281-2298 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i19/2281.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i19.2281 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
